✦ LIBER ✦

Multimodality cancer therapy in man: A pilot study of adriamycin by arterial infusion

✍ Scribed by Charles M. Haskell; Melvin J. Silverstein; Decio M. Rangel; John S. Hunt; Frank C. Sparks; Donald L. Morton

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 493 KB
Volume: 33
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197406)33:6<1485::aid-cncr2820330602>3.0.co;2-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A study of survival in patients with sto

A study of survival in patients with stomach cancer treated by a combination of preoperative intra-arterial infusion therapy and surgery

✍ Shigeru Fujimoto; Tateo Akao; Bunji Itoh; Itaru Koshizuka; Katsuji Koyano; Yukio 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 1 views

Intra-arterial infusion chemotherapy as

Intra-arterial infusion chemotherapy as an induction therapy in multidisciplinary treatment for locally advanced breast cancer. A long-term follow-up study

✍ Hiroki Koyama; Yukio Nishizawa; Tomio Wada; Toshiyuki Kabuto; Eiichi Shiba; Take 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 1 views

Combination modality therapy in lung can

Combination modality therapy in lung cancer. A survival study showing beneficial results of AMCOF (adriamycin, methotrexate, cyclophosphamide, oncovin and 5-fluorouracil)

✍ Dr. Colonel Ralph D. Reynolds; Colonel Stanley O'dell 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

Thirty-seven patients with advanced or recurrent lung cancer were randomized to cytoxan (CTX) alone, COMF (CTX, oncovin, methotrexate and 5-FU) or AMCOF (adriamycin, methotrexate, CTX, oncovin and 5-FU) after receiving radiation therapy to primary and bulky tumor sites. Median survival was 3 months